Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stuart Holden currently holds 20,000 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Holden has been a net neutral trader of URGN stock. They have purchased $0 and sold $0 worth of shares.
Stuart Holden's most recent insider trade was on Jun 22, 2026, when they sold 20,000 shares at $0.00 per share.
Stuart Holden serves as Executive at UroGen Pharma Ltd. (URGN). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Stuart Holden holds the position of Executive at UroGen Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Stuart Holden has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Stuart Holden was on Jun 22, 2026, when they purchased $0 worth of URGN shares. This transaction involved 20,000 shares at N/A per share.
Stuart Holden currently owns 20,000 shares of UroGen Pharma Ltd. (URGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stuart Holden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stuart Holden has 3 Form 4 filings on record as an insider at UroGen Pharma Ltd..
Set alerts for Stuart Holden and 40,000+ other insiders.